Everest Medicines Limited announced that the company's Board of Directors has appointed Kerry Blanchard, M.D., Ph.D., as director and Chief Executive Officer. He will also join the company's Board of Directors. Dr. Blanchard will be based in the company's Shanghai office.

In November 2019, Dr. Blanchard was appointed as Operating Partner of CBC Group. Previously, Dr. Blanchard was the Senior Vice President of Lilly China Drug Development and External Innovation. Interim CEO Sean Cao will transition to the role of senior advisor to the executive leadership team to support a smooth transition.